Indeed, Felsberg et al. [21], comparing the expression of MSH2, MSH6, MLH1, and PMS2 in primary and recurrent glioblastoma, demonstrated a significantly lower MSH2, MSH6, and PMS2 expression in recurrent GBM. Here, MLH1 is linked to glioblastoma.